Systematic review of the prevalence of Mycobacterium tuberculosis resistance in Saudi Arabia

References

• World Health Organization. Global tuberculosis control 2009: a short update to the 2009 report. Geneva, Switzerland: (WHO/HTM/TB/2009 426); 2010.
   Google Scholar
• Ministry of Health. Health statistical year book 1428 H (2007). Riyadh, Saudi Arabia 2008.
   Google Scholar
• Abouzeid MS, Zumla AI, Felemban S, Alotaibi B, O'Grady J, Memish ZA. Tuberculosis trends in Saudis and non-Saudis in the Kingdom of Saudi Arabia – a 10 year retrospective study (2000-2009). PLoS One. 2012;7(6):e39478.
   PubMedGoogle Scholar
• Khan MY, Kinsara AJ, Osoba AO, Wali S, Samman Y, Memish Z. Increasing resistance of M. tuberculosis to anti-TB drugs in Saudi Arabia. Int J Antimicrob Agents. 2001;17:415–8.
   PubMed Web of Science ®Google Scholar
• Abu-Amero KK. Status of antituberculosis drug resistance in Saudi Arabia 1979-98. East Mediterr Health J. 2002;8:664–70.
   PubMedGoogle Scholar
• Alrajhi AA, Al-Barrak AM. Mycobacterium tuberculosis susceptibility in Saudi Arabia. Saudi Med J. 2002;23:1227–31.
   PubMed Web of Science ®Google Scholar
• Al-Hajoj SA. Tuberculosis in Saudi Arabia: can we change the way we deal with the disease? J Infect Public Health. 2010;3:17–24.
   PubMedGoogle Scholar
• Yezli S, Memish ZA. Tuberculosis in Saudi Arabia: prevalence and antimicrobial resistance. J Chemother. 2012;24(1):1–5.
   PubMed Web of Science ®Google Scholar
• Neyeloff JL, Fuchs SC, Moreira LB. Meta-analyses and forest plots using a microsoft excel spreadsheet: step-by-step guide focusing on descriptive data analysis. BMC Res Notes. 2012;5:52.
   PubMedGoogle Scholar
• Whitehead A, Whitehead J. A general parametric approach to the metaanalysis of randomized clinical trials. Stat Med. 1991;10:1665–77.
   PubMed Web of Science ®Google Scholar
• 16.9.2 Studies with Zero-Cell Counts. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. [updated March 2011]. In: Julian PT Higgins J and S Green, Editors. Available from: http://handbook.cochrane.org/front_page.htm.
   Google Scholar
• Williams JG, Higgins JP, Brayne CE. Systematic review of prevalence studies of autism spectrum disorders. Arch Dis Child. 2006;91(1):8–15.
   PubMed Web of Science ®Google Scholar
• How to draw a funnel plot in Microsoft Excel. Available from: http://www.kurtosis.co.uk/technique/funnel/.
   Google Scholar
• Kordy FN, Al-Thawadi S, Alrajhi AA. Drug resistance patterns of Mycobacterium tuberculosis in Riyadh, Saudi Arabia. Int J Tuberc Lung Dis. 2004;8:1007–11.
   PubMed Web of Science ®Google Scholar
• al-Orainey IO, Saeed ES, el-Kassimi FA, al-Shareef N. Resistance to antituberculosis drugs in Riyadh, Saudi Arabia. Tubercle. 1989;70:207–10.
   PubMedGoogle Scholar
• Al-Hajjaj MS, Al-Kassimi FA, Al-Mobeireek AF, Alzeer AH. Progressive rise of Mycobacterium tuberculosis resistance to rifampicin and streptomycin in Riyadh, Saudi Arabia. Respirology. 2001;6(4):317–22.
   PubMedGoogle Scholar
• Ellis ME, al-Hajjar S, Bokhari H, Hussein Qadri SM. High proportion of multi-drug resistant Mycobacterium tuberculosis in Saudi Arabia. Scand J Infect Dis. 1996;28:591–5.
   PubMed Web of Science ®Google Scholar
• al-Orainey IO. Resistance to standard antituberculous drugs in Saudi Arabia. Saudi Med J. 1986;7:363–8.
   Web of Science ®Google Scholar
• Shanks NJ, Khalifa I, Al-Kalai D. Tuberculosis in Saudi Arabia. Saudi Med J. 1983;4:151–6.
   Google Scholar
• Chowdhury MNH, Kambal AM. Mycobacterial resistance in a general hospital in Riyadh Saudi Arabia. Med Sci Res. 1992;20:21–2.
   Google Scholar
• Singla R, Al-Sharif N, Al-Sayegh M, Osman M, Shaikh MA. Prevalence of resistance to antituberculosis drugs in Riyadh and a review of previous reports. Ann Saudi Med. 2003;23(3–4):143–7.
   PubMed Web of Science ®Google Scholar
• Al-Rasheed AM, Abu-Amero KK, Abdulsamad W, Alattayah S. Low prevalence of multi-drug resistance tuberculosis in Saudi patients: an eleven-year retrospective study (abstract). In: 20th Annual Congress of the European Society of Mycobacteriology; 1999; Lucerne, Switzerland.
   Google Scholar
• Somily AM, Naeem T, Habib HA, Sarwar MS, Kunimoto DY, Kambal AM. Changing epidemiology of tuberculosis detected by an 8-year retrospective laboratory study in a tertiary teaching hospital in central Saudi Arabia. Saudi Med J. 2014;35(7):691–8.
   PubMed Web of Science ®Google Scholar
• Kinsara A, Gilpin C, Osoba A. Review of tuberculosis at the King Khalid National Guard Hospital, Jeddah, Saudi Arabia. Saudi Med J. 1997;19:212–4.
   Web of Science ®Google Scholar
• Zaman R. Tuberculosis in Saudi Arabia: initial and secondary drug resistance among indigenous and nonindigenous populations. Tubercle. 1991;72:51–5.
   PubMedGoogle Scholar
• Al-Jama AA, Borgio FG, Al-Qatari KM. Patterns of resistance to antituberculous drugs in Eastern Province, Saudi Arabia. Saudi Med J. 1999;20:927–30.
   Web of Science ®Google Scholar
• Al-Tawfiq JA, Al-Muraikhy AA, Abed MS. Susceptibility pattern and epidemiology of Mycobacterium tuberculosis in a Saudi Arabian hospital. Chest. 2005;128:3229–32.
   PubMed Web of Science ®Google Scholar
• Al-Rubaish AM, Madania AA, Al-Muhanna FA. Drug resistance pulmonary tuberculosis in the Eastern Province of Saudi Arabia. Saudi Med J. 2001;22:776–9.
   PubMed Web of Science ®Google Scholar
• Ali Chaudhry L, Rambhala N, Al-Shammri AS, Al-Tawfiq JA. Patterns of antituberculous drug resistance in Eastern Saudi Arabia: a 7-year surveillance study from 1/2003 to 6/2010. J Epidemiol Glob Health. 2012;2(1):57–60.
   PubMedGoogle Scholar
• Al-Hajoj S, Varghese B, Shoukri MM, Al-Omari R, Al-Herbwai M, Alrabiah F, et al. Epidemiology of antituberculosis drug resistance in Saudi Arabia: findings of the first national survey. Antimicrob Agents Chemother. 2013;57(5):2161–6.
   PubMed Web of Science ®Google Scholar
• Alrajhi AA, Abdulwahab S, Almodovar E, Al-Abdely HM. Risk factors for drug-resistant Mycobacterium tuberculosis in Saudi Arabia. Saudi Med J. 2002;23:305–10.
   PubMed Web of Science ®Google Scholar
• Schiott C, Engbaek H, Vergmann B, Al-Motez M, Kassim I. Incidence of drug resistance amongst isolates of Mycobacterium tuberculosis recovered in Gizan area, Saudi Arabia. Saudi Med J. 1985;6:375–8.
   Web of Science ®Google Scholar
• Asaad AM, Alqahtani JM. Primary anti-tuberculous drugs resistance of pulmonary tuberculosis in southwestern Saudi Arabia. J Infect Public Health. 2012;5(4):281–5.
   PubMedGoogle Scholar
• Jarallah JS, Elias AK, Al Hajjaj MS, Bukhari MS, Al-Shareef AH, Al-Shammari SA. High rate of rifampicin resistance of Mycobacterium tuberculosis in the Taif region of Saudi Arabia. Tuber Lung Dis. 1992;73:113–5.
   PubMedGoogle Scholar
• Al-Rajhi AA, Al-Barrak AM. Extra-pulmonary tuberculosis, epidemiology and patterns in Saudi Arabia. Saudi Med J. 2002;23:503–8.
   PubMed Web of Science ®Google Scholar
• Al-Otaibi F, El Hazmi MM. Extra-pulmonary tuberculosis in Saudi Arabia. Indian J Pathol Microbiol. 2010;53(2):227–31.
   PubMed Web of Science ®Google Scholar
• The WHO Global TB Report. 2013. Available from: https://extranet.who.int/sree/Reports?op5Replet&name5%2FWHO_HQ_Reports%2FG2%2FPROD%2FEXT%2FTBCountryProfile&ISO25SA&LAN5EN&outtype5pdf.
   Google Scholar